[#LUNIT BRAND FILM] Conquer cancer through AI. "I get the feeling that we're really pioneering a new field every time we're on the job." Through AI, we unlock important clinical information that will help save more lives from cancer.

ASCO #GI23 starts tomorrow!🙌🇺🇸 Lunit will showcase two poster presentations that demonstrate the credibility of #Lunit_SCOPE_IO as a #biomarker to predict liver and colon cancer treatment outcomes.🦠🔬 ✅Read more:

We're starting 2023 with exciting news: Lunit has signed an agreement with Brazil's Hospital Israelita Albert Einstein! 🏥🤝 The hospital will operate Lunit INSIGHT CXR in its intensive care unit, emergency room, and in-patient examinations. ⬇️ Read more

A study published in The Lancet Regional Health - Americas suggests AI-based x-ray algorithms may improve TB screening in prisons. 🇧🇷🩺 Lunit's AI showed the most superior performance among the tested cohort, with greater accuracy and generalizability.🥇

🎉We've partnered with @CARPLai to deliver Lunit INSIGHT CXR and MMG in the U.S., Australia, Brazil, India, and Singapore!🤝 Our joint effort will enable easier access, affordability, and improved quality of medical care globally.🩺🌎 🔽 Read more

Lunit INSIGHT CXR and MMG have both received the MDR CE and UKCA certifications! 🎊🥳 With these two markings, Lunit is the first SaMD company in the APAC region to earn both certifications.🇬🇧🇪🇺 🔽 Read more:

In his keynote speech at the Microsoft Ignite Spotlight on Korea conference on Tuesday, Satya Nadella displayed Lunit as one of the representative Korean companies utilizing Microsoft Cloud to innovate and transform people's lives!🙌 🔽 Read More

Lunit is proud to join forces with @cancerNSW to supply our AI solution for the BreastScreen NSW (#BSNSW) State program! 🎉 Through the project, #Lunit_INSIGHT #MMG will assist radiologists in screening approx. 350,000 women per year.🇦🇺🙌 🔽Read more

#SITC22 starts tomorrow! 🙌 Lunit's presentations this year will focus on Lunit SCOPE IO's ability to accelerate immunotherapy clinical trials and drug development. 👏✨ 📍Visit us at booth #129 to get a hands-on demo of Lunit SCOPE IO!

Lunit is returning to Chicago for #RSNA22!🙌🇺🇸 With 7 oral presentations, this year's program will highlight real-world application studies of the Lunit INSIGHT suite.🩺 Stay tuned for more updates on Lunit at RSNA! ✔️ Read more:

Lunit is honored to join the World Economic Forum's (@wef) Global Innovators Community!🎊 We look forward to working closely with fellow global innovators to contribute our insights and expertise in the medical AI field to shape the future of healthcare.

Lunit will collaborate with @SEHAHealth to run an evaluation trial of the #Lunit_INSIGHT suite, our AI solution for radiology! Find out how we’ve teamed up with SEHA to help provide world-class medical AI solutions in the Middle East. 🙌🎉 Read more ➡️

"We've always concentrated on developing the 'best in class' products. That has been our key differentiator." Lunit CEO Brandon Suh discusses Lunit's IPO and future plans to scale up globally with @LaingBuisson.🌎🚀 ⬇️ Read more

Lunit X Re,move 💗 For Breast Cancer Awareness Month, Lunit created a breast self-examination guide in collaboration with healthy alternative underwear brand @_re_move 👏

October is Breast Cancer Awareness Month To show our support for everyone affected by breast cancer, we’ve changed the color of Lunit’s symbol to match the pink ribbon 🎀 #Lunit is dedicated to supporting the fight against breast cancer 💪 #BreastCancerAwarenessMonth

Watch our interview with Dr. Tony Mok, renowned cancer researcher and Lunit advisor, as he talks about Lunit's AI-powered biomarker and the future of cancer treatment led by AI. 🦠🔬

Lunit AI Research Conference 2022 begins!🚀🎊 Every year, The Lunit AI research team gathers together to debate and solve problems to conquer cancer through AI.🧑🏻‍💻 We can't wait to see what kind of research presentations and discussions we have in line for this year!🔥

How can AI improve radiologist’s confidence?🤔 Prof. Fernando Kay’s recent research shows how Lunit’s AI can help medical staff improve their chest x-ray analysis skills.👨🏻‍⚕️🦾 Watch to learn more about his research and his insights in AI for radiology!

A new study, published in @JAMANetworkOpen, found that radiologists showed significant improvement in reader performance and efficiency in diagnosing major chest abnormalities with the assistance of Lunit INSIGHT CXR. ✔️Read the full study ⬇️

Another FDA clearance! This time, Lunit INSIGHT MMG received #commercial approval in Taiwan.✨ Following our partnership with Cathay Life Insurance, we're expanding the reach of our #AI solution throughout Asia and across the globe. ✔️Read more ⬇️

"It's important to treat patients in hospitals, but a way to make a difference in a larger area is to find new biomarkers." Chan-Young Ock, CMO of Lunit's Oncology Group, discusses #immunotherapy and Lunit's long-term vision. ✔️Read more ⬇️